foxo4-dri senolytic peptide human trials

foxo4-dri senolytic peptide human trials improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri senolytic peptide human trials improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells Peptide inhibitors targeting FOXO4-p53 interactions
Brand: kongresftb.pl
SKU: 33870311760
Price: 22.89 USD
Availability: InStock
Rating: 4.7083 (8 reviews)

SKU: 33870311760

4.7

EUR22.89 EUR47.89

Pay in 4 interest-free payments of $5.72 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 17 - Sep 22

Description

an impure compound means you're not administering the intended amount of active substance

Each peptide is provided at a quantified content of 5 mg per vial

Data Following subcutaneous administration of a single 5 mg dose to 11 healthy lactating adult females, the concentration of tirzepatide in breast milk was found to be undetectable (limit of detection in breast milk 4 ng/mL) in 164/171 samples assayed